Mark Zuckerberg and Priscilla Chan are shifting their philanthropic focus to combine AI and biology in a bid to cure diseases. Their initiative, called Biohub, aims to accelerate research by creating digital models of biological processes. This move has sparked some controversy due to the closure of previous projects benefiting local communities.

This article discusses the Chan Zuckerberg Initiative's Biohub, highlighting its efforts to revolutionize biology and health through AI. It covers their significant investments, groundbreaking research, and the development of models aimed at understanding the immune system and other complex biological processes.